JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$4.16B |
| 2 |
Microsoft
MSFT
|
+$2.29B |
| 3 |
Amazon
AMZN
|
+$2B |
| 4 |
UnitedHealth
UNH
|
+$1.76B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.42B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.61B |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.58B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$689M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$659M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.28% |
| 2 | Technology | 15.04% |
| 3 | Healthcare | 12.52% |
| 4 | Financials | 10.55% |
| 5 | Consumer Discretionary | 7.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
DHC
2201
Diversified Healthcare Trust
DHC
$1.87B
| $8.57M | ﹤0.01% |
4,710,072
+1,031,265
| +28% | +$2.36M |
2020 Q1
9 quarters
|
|
2202
Cars.com
CARS
$535M
| $8.57M | ﹤0.01% |
908,599
+139,744
| +18% | +$1.51M |
2017 Q2
20 quarters
|
|
2203
Arcosa
ACA
$7.19B
| $8.55M | ﹤0.01% |
184,093
+14,376
| +8% | +$753K |
2018 Q4
14 quarters
|
|
2204
Carnival Corporation Ltd
CCL
$33.7B
| $8.53M | ﹤0.01% |
985,651
+191,732
| +24% | +$2.81M |
2013 Q2
36 quarters
|
|
2205
Gerdau
GGB
$9.44B
| $8.49M | ﹤0.01% |
2,494,538
-2,357,731
| -49% | -$10.5M |
2013 Q2
36 quarters
|
|
|
BLU
2206
DELISTED
BELLUS Health Inc.
BLU
| $8.47M | ﹤0.01% |
916,915
-242,818
| -21% | -$1.99M |
2021 Q3
3 quarters
|
|
2207
Alpha Metallurgical Resources
AMR
$2.16B
| $8.47M | ﹤0.01% |
65,600
-21,596
| -25% | -$3.26M |
2018 Q4
14 quarters
|
|
2208
CVR Energy
CVI
$5.46B
| $8.45M | ﹤0.01% |
252,220
-42,571
| -14% | -$1.36M |
2013 Q2
36 quarters
|
|
2209
CALL
Verizon
VZ
$191B
| $8.45M | ﹤0.01% |
166,400
-167,000
| -50% | -$8.45M |
2020 Q2
8 quarters
|
|
2210
PUT
American Express
AXP
$204B
| $8.44M | ﹤0.01% |
60,900
+24,600
| +68% | +$4.06M |
2016 Q1
25 quarters
|
|
2211
First Busey Corp
BUSE
$2.43B
| $8.44M | ﹤0.01% |
369,448
-30,551
| -8% | -$710K |
2013 Q2
36 quarters
|
|
2212
Invesco S&P 500 Equal Weight Health Care ETF
RSPH
$853M
| $8.41M | ﹤0.01% |
313,780
-6,240
| -2% | -$177K |
2018 Q3
15 quarters
|
|
2213
Enanta Pharmaceuticals
ENTA
$374M
| $8.4M | ﹤0.01% |
177,654
+138,097
| +349% | +$7.49M |
2016 Q1
25 quarters
|
|
2214
News Corp Class A
NWSA
$15.4B
| $8.39M | ﹤0.01% |
538,480
-106,132
| -16% | -$1.95M |
2013 Q3
35 quarters
|
|
|
GOOD
2215
Gladstone Commercial Corp
GOOD
$616M
| $8.36M | ﹤0.01% |
443,931
-7,921
| -2% | -$161K |
2013 Q3
35 quarters
|
|
2216
Crocs
CROX
$5.72B
| $8.36M | ﹤0.01% |
171,653
+11,065
| +7% | +$672K |
2013 Q2
36 quarters
|
|
|
CMAX
2217
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
| $8.35M | ﹤0.01% |
76,688
+5,833
| +8% | +$1M |
2021 Q4
2 quarters
|
|
2218
PVH
PVH
$3.5B
| $8.35M | ﹤0.01% |
146,690
-58,504
| -29% | -$4.04M |
2013 Q2
36 quarters
|
|
2219
CALL
Starbucks
SBUX
$108B
| $8.34M | ﹤0.01% |
109,200
+1,800
| +2% | +$138K |
2016 Q1
25 quarters
|
|
2220
PUT
Oracle
ORCL
$419B
| $8.32M | ﹤0.01% |
119,100
-15,900
| -12% | -$1.16M |
2015 Q3
27 quarters
|
|
2221
Zai Lab
ZLAB
$2.86B
| $8.32M | ﹤0.01% |
239,810
-50,939
| -18% | -$1.8M |
2020 Q1
9 quarters
|
|
2222
Pathward Financial
CASH
$1.53B
| $8.3M | ﹤0.01% |
214,630
+5,765
| +3% | +$246K |
2015 Q2
28 quarters
|
|
2223
iShares Low Carbon Optimized MSCI ACWI ETF
CRBN
$1.16B
| $8.29M | ﹤0.01% |
60,615
+5,423
| +10% | +$806K |
2015 Q4
26 quarters
|
|
|
SEM
2224
DELISTED
Select Medical
SEM
| $8.29M | ﹤0.01% |
651,408
-163,836
| -20% | -$2.1M |
2015 Q2
28 quarters
|
|
2225
Dana Inc
DAN
$2.97B
| $8.29M | ﹤0.01% |
589,174
-94,049
| -14% | -$1.46M |
2013 Q2
36 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2022 Portfolio in Review
As of Q2 2022, JP Morgan Chase held 7,270 positions worth $718B, down 14% from $830B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2022 filing shows 568 new, 2,561 increased, 2,728 reduced and 609 closed positions. Its largest new stake was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $4.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q2 2022 buy was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B.
- JP Morgan Chase added most to Microsoft in Q2 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q2 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $4.61B.
- JP Morgan Chase fully exited Cerner Corp in Q2 2022, selling an estimated $608M.
- JP Morgan Chase's ten largest holdings make up 18% of its $718B portfolio in Q2 2022.
- JP Morgan Chase opened 568 new positions and closed 609 in Q2 2022.
- JP Morgan Chase's portfolio value fell 14% quarter-over-quarter to $718B.
Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.